Lhermie Guillaume, Gröhn Yrjö T, Raboisson Didier
Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, IthacaNY, USA; BioEpar, Oniris, Institut National de la Recherche Agronomique (INRA)Nantes, France.
Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca NY, USA.
Front Microbiol. 2017 Jan 6;7:2114. doi: 10.3389/fmicb.2016.02114. eCollection 2016.
The growing concern regarding emergence of bacteria resistant to antimicrobials and their potential for transmission to humans via animal production has led various authorities worldwide to implement measures to decrease antimicrobial use (AMU) in livestock production. These measures are influenced by those implemented in human medicine, and emphasize the importance of antimicrobial stewardship, surveillance, infection prevention and control and research. In food producing animals, unlike human medicine, antimicrobials are used to control diseases which cause economic losses. This major difference may explain the failure of the public policies implemented to control antimicrobial usage. Here we first review the specific factors influencing AMU across the farm animal sector and highlighting the farmers' decision-making process of AMU. We then discuss the efficiency of existing regulations implemented by policy makers, and assess the need for alternative strategies, such as substitution between antimicrobials and other measures for infectious disease control. We also discuss the interests of regulating antimicrobial prices. Finally, we emphasize the value of optimizing antimicrobial regimens, and developing veterinary precision medicine to achieve clinical efficacy in animals while limiting negative impacts on public health. The fight against antimicrobial resistance requires both a reduction and an optimization of antimicrobial consumption. The set of actions currently implemented by policy makers does not adequately address the economic interests of farmers' use of antimicrobials.
人们越来越担心抗菌药物耐药菌的出现以及它们通过动物生产传播给人类的可能性,这促使世界各地的有关当局采取措施减少畜牧业中的抗菌药物使用(AMU)。这些措施受到人类医学领域所采取措施的影响,强调了抗菌药物管理、监测、感染预防与控制以及研究的重要性。在食用动物中,与人类医学不同,抗菌药物用于控制会造成经济损失的疾病。这一重大差异或许可以解释为控制抗菌药物使用而实施的公共政策为何失败。在此,我们首先回顾影响整个农场动物部门抗菌药物使用的具体因素,并着重探讨农民使用抗菌药物的决策过程。然后,我们讨论政策制定者实施的现有法规的有效性,并评估是否需要替代策略,例如抗菌药物之间的替代以及其他传染病控制措施。我们还讨论了调控抗菌药物价格的益处。最后,我们强调优化抗菌药物治疗方案以及发展兽医精准医学的价值,以便在动物身上实现临床疗效,同时限制对公众健康的负面影响。对抗抗菌药物耐药性既需要减少抗菌药物的使用,也需要优化抗菌药物的使用。政策制定者目前实施的一系列行动并未充分顾及农民使用抗菌药物的经济利益。